Inhibition of human immunodeficiency virus type 1 by niclosamide through mTORC1 inhibition
Niclosamide has been known to inhibit a number of pH-dependent viruses via the neutralization of endosomal acidic pH. It has also been shown to disrupt the mTORC1 signaling pathway. The replication of many viruses requires mTORC1 activation. Here, we investigated the inhibitory activity of niclosami...
Main Authors: | Nattamon Niyomdecha, Ornpreya Suptawiwat, Chompunuch Boonarkart, Kunlakunya Jitobaom, Prasert Auewarakul |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-06-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S240584402030894X |
Similar Items
-
Human Schlafen 11 inhibits influenza A virus production
by: Kunlakanya Jitobaom, et al.
Published: (2023-09-01) -
A randomized trial to assess the acceleration of viral clearance by the combination Favipiravir/Ivermectin/Niclosamide in mild-to-moderate COVID-19 adult patients (FINCOV)
by: Taweegrit Siripongboonsitti, et al.
Published: (2024-05-01) -
Synergistic anti-SARS-CoV-2 activity of repurposed anti-parasitic drug combinations
by: Kunlakanya Jitobaom, et al.
Published: (2022-06-01) -
Niclosamide Ethanolamine Salt Alleviates Idiopathic Pulmonary Fibrosis by Modulating the PI3K-mTORC1 Pathway
by: Xiaolin Pei, et al.
Published: (2022-01-01) -
Codon usage similarity between viral and some host genes suggests a codon-specific translational regulation
by: Kunlakanya Jitobaom, et al.
Published: (2020-05-01)